Over $30B In Trust Funds Are Available For Mesothelioma Victims & Their Families - Click Here To Claim Your Share

Talk to a mesothelioma nurse specialist

Working with an experienced mesothelioma nurse can help you:

  • Avoid delays in care
  • Identify the right doctors faster
  • Understand complex treatment decisions
  • Access clinical trials you may not otherwise find

Get guidance from Mary Hesdorffer, a nationally recognized mesothelioma expert with over 30 years of experience helping patients navigate treatment, specialists and clinical trials.

  • Understand your diagnosis
  • Explore treatment options
  • Connect with top mesothelioma doctors
  • Get clinical trial referrals

 

About Mary Hesdorffer

  • Former Executive Director, Mesothelioma Applied Research Foundation (curemeso.org)
  • Contributor to research with the National Cancer Institute
  • Co-author with leading mesothelioma specialist Dr. Harvey Pass

Read Mary Hesdorffer’s full bio here.

Why getting help from an expert matters

  • Avoid delays in care
  • Identify the right doctors faster
  • Understand complex treatment decisions
  • Access clinical trials you may not otherwise find

Frequently Asked Questions (FAQ)

Is there a cost to speak with Mary?
No. This is a free service provided to help you understand your options.

Will this affect my legal case?
No. This is strictly medical guidance and support.

How quickly will I hear back?
Typically, within one business day.

How Can We Help?

This field is for validation purposes and should be left unchanged.

Mass Tort Top 25 Trial Lawyers award badge
The National Trial Lawyers Top 100 award badge
America's Top 100 High Stakes Litigators
National Association of Distinguished Counsel
Martindale-Hubbell AV Preeminent for Ethical Standards and Legal Ability
Million Dollar Advocates Forum
Best Lawyers: Linking Lawyers and Clients Worldwide
Lead Counsel verified attorneys
Super Lawyers
The National Law Journal
Better Business Bureau Accredited Business
Avvo Top Attorney 10.0 Rating
AAJ Leaders Forum Benefactor 2023
AAJ Leaders Forum Benefactor 2024

A track record of success

$83M

Verdict for the family of a woman exposed to asbestos by working with clay

$32M

Verdict for navy veteran exposed to asbestos on ship

$22M

Verdict for a construction worker exposed to asbestos

News

There are currently three FDA-approved treatments for mesothelioma: chemotherapy with two drugs (approved in 2004); immunotherapy with two drugs (approved in 2020); and combination chemotherapy with immunotherapy (approved in 2024). Other treatment options may be available through experimental clinical trials.

The American Society of Clinical Oncology (ASCO) published an update to its 2018 guideline for the treatment of pleural mesothelioma. This summary of the guidelines is based on the published manuscriptTreatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights. JCO Oncol Pract. 2025 Mar.

Despite a lack of approved standard treatment/s for peritoneal mesothelioma, experts have come together to identify areas of consensus in what constitutes the best practices in treatment. This compilation of guidelines is an update on a previous iteration from 2018.

A new study suggests that in some very select instances, operating on pleural sarcomatoid mesothelioma could improve outcomes for those patients. For the full study, and a more nuanced write-up, click the image to read more.

Belluck Law is expanding its client support services by adding to our team Mary Hesdorffer, RN, MSN a leading expert in mesothelioma care. With decades of experience in patient care, research, and advocacy, Mary will help support our mesothelioma and lung cancer clients as they navigate treatment options, specialists, and clinical trials.

Meet the Belluck Law Team

Get guidance from Mary Hesdorffer, a nationally recognized mesothelioma expert with over 30 years of experience helping patients navigate treatment, specialists and clinical trials.

 

About Mary Hesdorffer

  • Former Executive Director, Mesothelioma Applied Research Foundation (curemeso.org)
  • Contributor to research with the National Cancer Institute
  • Co-author with leading mesothelioma specialist Dr. Harvey Pass

Read Mary Hesdorffer’s full bio here.

Why getting help from an expert matters

  • Avoid delays in care
  • Identify the right doctors faster
  • Understand complex treatment decisions
  • Access clinical trials you may not otherwise find

Frequently Asked Questions (FAQ)

Is there a cost to speak with Mary?
No. This is a free service provided to help you understand your options.

Will this affect my legal case?
No. This is strictly medical guidance and support.

How quickly will I hear back?
Typically, within one business day.

Get a Free Consultation

This field is for validation purposes and should be left unchanged.

You don't pay unless we win!

Mary Hesdorffer has contributed to the scientific field by:

  • Former Executive Director of the Mesothelioma Applied Research Foundation (curemeso.org) – the only independent mesothelioma organization in the country
  • Co-authoring peer-reviewed medical papers on mesothelioma treatment and management published in major medical journals;
  • Participating in major consensus reports in collaboration with institutions like the National Cancer Institute;
  • Co-editing and authoring the book Caring for Patients with Mesothelioma, which focuses on long-term care and survivorship;
  • Co-authoring the best-selling book 100 Questions & Answers about Mesothelioma with Dr. Harvery Pass and Joseph Belluck, Esq.
  • She has testified before Congress on the link between mesothelioma and military service, advocating for dedicated federal research funding for this historically underfunded cancer.
  • She has successfully advocated for the Congressionally Directed Medical and Cancer Research Programs’ funding that has so far resulted in nearly $30 million directed toward mesothelioma research.
  • Under Mary Hesdorffer’s leadership, the Mesothelioma Applied Research Foundation: Funded millions of dollars in peer-reviewed research
  • Connected patients with top specialists and clinical trials Elevated national awareness of the disease through media and public speaking engagements.